Main Menu

Milacron Holdings Corp.

(NYSE: MCRN)

Summary

Attention investors who purchased shares of Milacron Holdings Corp. before July 12, 2019:

Rigrodsky & Long is investigating potential claims against the board of directors of Milacron Holdings Corp. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to merge with Hillenbrand, Inc., Inc. in at transaction valued at approximately $2 billion.

Press Release

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Milacron Holdings Corp. (“Milacron” or the “Company”) (NYSE: MCRN) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to merge with Hillenbrand, Inc. (“Hillenbrand”) (NYSE: HI) in a transaction valued at approximately $2 billion.  Under the terms of the agreement, shareholders of Milacron will receive $11.80 in cash and 0.1612 shares of Hillenbrand common stock for each share of Milacron owned. Upon closing, Hillenbrand shareholders will own approximately 84% of the combined company and Milacron stockholders will own approximately 16% of the combined company.

If you own common stock of Milacron and purchased any shares before July 12, 2019, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra toll-free at (888) 969-4242, by e-mail at info@rl-legal.com, or at https://www.rigrodskylong.com/offices-contact.  

Rigrodsky & Long, P.A., with offices in Delaware, New York, and California, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in numerous cases nationwide, including federal securities fraud actions, shareholder class actions, and shareholder derivative actions.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Back to Page